Logo image of LFST

LIFESTANCE HEALTH GROUP INC (LFST) Stock Fundamental Analysis

NASDAQ:LFST - Nasdaq - US53228F1012 - Common Stock - Currency: USD

7.7  -0.19 (-2.41%)

After market: 7.59 -0.11 (-1.43%)

Fundamental Rating

3

Overall LFST gets a fundamental rating of 3 out of 10. We evaluated LFST against 108 industry peers in the Health Care Providers & Services industry. The financial health of LFST is average, but there are quite some concerns on its profitability. LFST is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year LFST has reported negative net income.
In the past year LFST had a positive cash flow from operations.
LFST had negative earnings in each of the past 5 years.
In multiple years LFST reported negative operating cash flow during the last 5 years.
LFST Yearly Net Income VS EBIT VS OCF VS FCFLFST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -100M -200M -300M

1.2 Ratios

LFST has a worse Return On Assets (-4.52%) than 61.68% of its industry peers.
LFST's Return On Equity of -6.63% is in line compared to the rest of the industry. LFST outperforms 48.60% of its industry peers.
Industry RankSector Rank
ROA -4.52%
ROE -6.63%
ROIC N/A
ROA(3y)-12.2%
ROA(5y)-15.48%
ROE(3y)-16.5%
ROE(5y)-24.55%
ROIC(3y)N/A
ROIC(5y)N/A
LFST Yearly ROA, ROE, ROICLFST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 -10 -20 -30 -40

1.3 Margins

LFST does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LFST Yearly Profit, Operating, Gross MarginsLFST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -20 -40 -60 -80

More info and screens

4

2. Health

2.1 Basic Checks

LFST does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LFST has more shares outstanding
LFST has a worse debt/assets ratio than last year.
LFST Yearly Shares OutstandingLFST Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 100M 200M 300M
LFST Yearly Total Debt VS Total AssetsLFST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 2.67 indicates that LFST is not a great score, but indicates only limited risk for bankruptcy at the moment.
LFST has a Altman-Z score (2.67) which is in line with its industry peers.
LFST has a debt to FCF ratio of 8.04. This is a slightly negative value and a sign of low solvency as LFST would need 8.04 years to pay back of all of its debts.
LFST has a better Debt to FCF ratio (8.04) than 63.55% of its industry peers.
A Debt/Equity ratio of 0.19 indicates that LFST is not too dependend on debt financing.
LFST has a better Debt to Equity ratio (0.19) than 69.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 8.04
Altman-Z 2.67
ROIC/WACCN/A
WACC8.86%
LFST Yearly LT Debt VS Equity VS FCFLFST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.32 indicates that LFST should not have too much problems paying its short term obligations.
LFST has a Current ratio (1.32) which is in line with its industry peers.
LFST has a Quick Ratio of 1.32. This is a normal value and indicates that LFST is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.32, LFST is in line with its industry, outperforming 48.60% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 1.32
LFST Yearly Current Assets VS Current LiabilitesLFST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

6

3. Growth

3.1 Past

LFST shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.00%, which is quite impressive.
Looking at the last year, LFST shows a very strong growth in Revenue. The Revenue has grown by 20.07%.
LFST shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 40.92% yearly.
EPS 1Y (TTM)50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.24%
Revenue 1Y (TTM)20.07%
Revenue growth 3Y40.92%
Revenue growth 5YN/A
Sales Q2Q%18.95%

3.2 Future

LFST is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.29% yearly.
Based on estimates for the next years, LFST will show a quite strong growth in Revenue. The Revenue will grow by 15.12% on average per year.
EPS Next Y65.5%
EPS Next 2Y32.48%
EPS Next 3Y24.29%
EPS Next 5YN/A
Revenue Next Year19.38%
Revenue Next 2Y15.81%
Revenue Next 3Y15.12%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LFST Yearly Revenue VS EstimatesLFST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
LFST Yearly EPS VS EstimatesLFST Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

LFST reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year LFST is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LFST Price Earnings VS Forward Price EarningsLFST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60

4.2 Price Multiples

LFST's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. LFST is more expensive than 61.68% of the companies in the same industry.
LFST's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 84.02
EV/EBITDA 217.46
LFST Per share dataLFST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

A more expensive valuation may be justified as LFST's earnings are expected to grow with 24.29% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.48%
EPS Next 3Y24.29%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LFST!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIFESTANCE HEALTH GROUP INC

NASDAQ:LFST (2/21/2025, 8:00:02 PM)

After market: 7.59 -0.11 (-1.43%)

7.7

-0.19 (-2.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)02-27 2025-02-27/bmo
Inst Owners35.32%
Inst Owner Change2.18%
Ins Owners6.62%
Ins Owner Change-0.02%
Market Cap2.95B
Analysts80
Price Target8.98 (16.62%)
Short Float %8%
Short Ratio8.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)40.85%
Min EPS beat(2)10.6%
Max EPS beat(2)71.11%
EPS beat(4)3
Avg EPS beat(4)22.59%
Min EPS beat(4)-26.69%
Max EPS beat(4)71.11%
EPS beat(8)5
Avg EPS beat(8)-5.8%
EPS beat(12)6
Avg EPS beat(12)-9.41%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.44%
Min Revenue beat(2)-0.44%
Max Revenue beat(2)1.32%
Revenue beat(4)2
Avg Revenue beat(4)1%
Min Revenue beat(4)-1.49%
Max Revenue beat(4)4.6%
Revenue beat(8)5
Avg Revenue beat(8)1.13%
Revenue beat(12)6
Avg Revenue beat(12)0.02%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.15%
PT rev (3m)11.16%
EPS NQ rev (1m)36.2%
EPS NQ rev (3m)37.82%
EPS NY rev (1m)11.54%
EPS NY rev (3m)25.92%
Revenue NQ rev (1m)0.44%
Revenue NQ rev (3m)0.75%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)0.96%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.44
P/FCF 84.02
P/OCF 47.72
P/B 2.05
P/tB N/A
EV/EBITDA 217.46
EPS(TTM)-0.26
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)0.09
FCFY1.19%
OCF(TTM)0.16
OCFY2.1%
SpS3.15
BVpS3.76
TBVpS-0.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.52%
ROE -6.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 2.91%
ROA(3y)-12.2%
ROA(5y)-15.48%
ROE(3y)-16.5%
ROE(5y)-24.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 8.04
Debt/EBITDA 18.97
Cap/Depr 33.98%
Cap/Sales 2.21%
Interest Coverage N/A
Cash Conversion 419.77%
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 1.32
Altman-Z 2.67
F-Score6
WACC8.86%
ROIC/WACCN/A
Cap/Depr(3y)113.15%
Cap/Depr(5y)139.33%
Cap/Sales(3y)9.07%
Cap/Sales(5y)8.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.24%
EPS Next Y65.5%
EPS Next 2Y32.48%
EPS Next 3Y24.29%
EPS Next 5YN/A
Revenue 1Y (TTM)20.07%
Revenue growth 3Y40.92%
Revenue growth 5YN/A
Sales Q2Q%18.95%
Revenue Next Year19.38%
Revenue Next 2Y15.81%
Revenue Next 3Y15.12%
Revenue Next 5YN/A
EBIT growth 1Y68.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year155.96%
EBIT Next 3Y41.44%
EBIT Next 5YN/A
FCF growth 1Y158.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y29.95%
OCF growth 3YN/A
OCF growth 5YN/A